News Detail
New Delhi, 5 Sept 2024: The Division Bench of the Delhi High Court has issued an interim order in relief to around 16 companies who approached the Court against the Centre's recent notifications banning 156 fixed dose combinations (FDCs) stating them as irrational combinations.
Source : Pharmabiz
Division Bench
Delhi High Court
FDCs
Cipla
Zydus
Mankind
Alkem
Intas
Bharat Serums
Entod Pharma
Leeford Healthcare
Mankind Prime Labs
Laborate Pharma
Indchemie Health Specialities
DWD Pharmaceuticals
Pharm Products DTAB
Section 26A
Drugs and Cosmetics Act
Related News
- 2 antibiotic classes banned for use in animal rearing (13-03-2025)
- DoP organises workshop on PRIP Scheme (13-03-2025)
- Centre and States Prepare to Combat Narcotic Drug Abuse, May Require Barcodes on Packaging (13-03-2025)
- Large consignment of cough syrup recovered before Holi in Madhubani (13-03-2025)
- Poly Medicure gets MDR certification complying EU regulation for 54 products (13-03-2025)
- Assam Rifles, Customs Seize ₹99 Lakh Worth of Banned Phensedyl in Tripura (13-03-2025)
- Treatment of Patients by Unlicensed Practitioners at Medical Store (13-03-2025)
- HC reprimands Punjab for delay in drug probe, sets 10-day limit (13-03-2025)
- Expired Medicine Issue Raised in Assembly (13-03-2025)
- Counterfeiting of medical devices is a severe offense that jeopardizes human lives: Delhi HC (12-03-2025)